Skip to main content

Day: January 21, 2021

Mortgage Rates Move Slightly

MCLEAN, Va., Jan. 21, 2021 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today released the results of its Primary Mortgage Market Survey (PMMS), showing that the 30-year fixed-rate mortgage (FRM) averaged 2.77 percent.“Mortgage rates have hovered near historic lows for almost a year, fueling purchase and refinance activity amid a global health crisis,” said Sam Khater, Freddie Mac’s Chief Economist. “We’re now seeing rates fluctuate a bit as political and economic factors drive Treasury yields higher. However, we forecast rates to remain relatively low this year as the Federal Reserve keeps interest rates anchored near zero for a longer period of time, if needed until the economy rebounds.”News Facts30-year fixed-rate mortgage averaged 2.77 percent with an average 0.7 point for the week ending January 21, 2021, down from last week...

Continue reading

CN Employees’ and Pensioners’ Community Fund Has Raised More Than 2M$ for its 2021 Fundraising Campaign

MONTREAL, Jan. 21, 2021 (GLOBE NEWSWIRE) — CN (TSX: CNR)(NYSE: CNI) is proud to announce today that the CN Employees’ and Pensioners’ Community Fund (the Community Fund) 2021 campaign was able to raise more than C$2 million for various non-profit organizations in a moment where the need is greater than ever.“We are living through unprecedented times, and while the impacts of the current pandemic are many, it is particularly affecting society’s most vulnerable. CN employees and pensioners have been incredibly generous once again.  We are deeply thankful for their kindness and compassion, and their willingness to pay it forward.”Janet Drysdale, CN’s vice-president, financial planning and co-chair of the annual campaignMore than 500 non-profit organizations working in various fields such as health and research,...

Continue reading

La Caisse de bienfaisance des employés et retraités du CN a récolté plus de 2 M$ pour sa campagne de financement 2021

MONTRÉAL, 21 janv. 2021 (GLOBE NEWSWIRE) — Le CN (TSX : CNR) (NYSE : CNI) est fier d’annoncer aujourd’hui que la campagne 2021 de la Caisse de bienfaisance des employés et des retraités du CN (la Caisse de bienfaisance) a été en mesure de récolter une somme de plus de 2 M$ CA pour différents organismes sans but lucratif, et ce, dans un contexte où les besoins sont plus importants que jamais.« Nous traversons une période sans précédent, et bien que les impacts de la pandémie actuelle soient nombreux, ils touchent particulièrement les plus vulnérables. Les membres du personnel et les retraités du CN ont été encore une fois d’une générosité incroyable et nous pouvons être fiers de la solidarité et de la compassion dont ont fait part, encore une fois cette année, l’ensemble des donateurs. »Janet Drysdale, Vice-présidente Planification...

Continue reading

MDxHealth Launches Capital Increase and Provides Preliminary 2020 Financial Results

THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE PROHIBITED BY APPLICABLE LAWNEWS RELEASE – REGULATED INFORMATION – INSIDE INFORMATION21 January 2021, 04:00 p.m. CETIRVINE, CA, and HERSTAL, BELGIUM – 21 January 2021 – MDxHealth SA (Euronext Brussels: MDXH) (the “Company” or “MDxHealth“), a commercial-stage innovative molecular diagnostics company, announces the launch of a capital increase with the offering of new ordinary shares by means of a private placement via an accelerated bookbuild offering (the “Capital Increase“).Preliminary 2020 Financial ResultsMDxHealth ended the fourth quarter of 2020 with second consecutive sequential increase in billable volume for...

Continue reading

DIAGNOS Successfully Completes ISO 13485 / MDSAP Audit

BROSSARD, Quebec, Jan. 21, 2021 (GLOBE NEWSWIRE) — Diagnos Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today that its quality management system continues to comply with the applicable regulatory requirements for medical devices.As part of the requirements for the commercialization of our flagship product CARA from Health Canada and the Food and Drug Agency in the US (FDA), DIAGNOS must undergo thorough statutory annual quality compliance audits under the Medical Device Single Audit Program (MDSAP). MDSAP is a comprehensive approach to quality management systems auditing among countries devoted to enhance the safety of medical devices.“I would like to take...

Continue reading

DIAGNOS complète avec succès l’audit ISO 13485 / PAUMM

BROSSARD, Québec, 21 janv. 2021 (GLOBE NEWSWIRE) — Diagnos inc. (« DIAGNOS », la « Société » ou « nous ») (Bourse de croissance TSX : ADK) (OTCQB : DGNOF), un leader dans le dépistage précoce de problèmes graves de santé grâce à sa technologie d’intelligence artificielle (IA) FLAIRE, annonce aujourd’hui que son système de gestion de la qualité continue de se conformer aux exigences règlementaires concernant les instruments médicaux applicables à DIAGNOS.Dans le cadre des exigences de Santé Canada et de la Food and Drug Administration (FDA) aux États-Unis relatives à la commercialisation de notre produit phare CARA, DIAGNOS doit obligatoirement se soumettre à un processus rigoureux d’audit annuel de conformité de son système de qualité, soit le Programme d’Audit Unique pour le Matériel Médical (PAUMM). Le PAUMM est une approche globale...

Continue reading

GTX Corp Signs Collaboration Agreement with Pawtocol

LOS ANGELES, CALIFORNIA, Jan. 21, 2021 (GLOBE NEWSWIRE) — GTX Corp (OTC: GTXO) (“GTX” or the “Company”), a pioneer in the field of health and safety wearable GPS human and asset tracking systems, and a supplier of personal protective equipment (“PPE”), announced today it has signed a collaboration agreement with Pawtocol, a Miami based global online community for the pet industry.Under the agreement GTX will explore integrating IoT sensors and embedded tech to collect and share pet data, leveraging Pawtocol’s blockchain technology. GTX’s Rover Tracker, which is a GPS and NFC IoT device designed for the rapid recovery and profile identification of pets, will be the first device tested on the platform.Pawtocol’s blockchain technology provides users privacy and security features, including complete control of their data and the ability...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.